Impact of metabolic syndrome on no-reflow after primary percutaneous coronary intervention in patients with acute ST elevation myocardial infarction.
Celik
Turgay
T
Iyisoy
Atila
A
D015906:Angioplasty, Balloon, Coronary / Q000009:adverse effects*; D003326:Coronary Circulation; D006801:Humans; D024821:Metabolic Syndrome / Q000150:complications* / Q000503:physiopathology; D008833:Microcirculation / Q000503:physiopathology; D009203:Myocardial Infarction / Q000150:complications / Q000503:physiopathology / Q000628:therapy*; D054318:No-Reflow Phenomenon / Q000209:etiology* / Q000503:physiopathology; D012307:Risk Factors; D016896:Treatment Outcome